The buprenorphine market is estimated to be valued at US$ 5526.99 Mn in 2023 and is expected to exhibit a CAGR of 14.%
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |